NBIX logo

Neurocrine Biosciences (NBIX) Operating profit

annual operating profit:

$583.00M+$188.20M(+47.67%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual operating income is $583.00 million, with the most recent change of +$188.20 million (+47.67%) on December 31, 2024.
  • During the last 3 years, NBIX annual operating profit has risen by +$375.20 million (+180.56%).
  • NBIX annual operating profit is now at all-time high.

Performance

NBIX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

quarterly operating profit:

$23.70M-$121.30M(-83.66%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly operating income is $23.70 million, with the most recent change of -$121.30 million (-83.66%) on March 31, 2025.
  • Over the past year, NBIX quarterly operating profit has dropped by -$81.60 million (-77.49%).
  • NBIX quarterly operating profit is now -87.18% below its all-time high of $184.80 million, reached on September 30, 2024.

Performance

NBIX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

TTM operating profit:

$501.40M-$81.60M(-14.00%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX TTM operating income is $501.40 million, with the most recent change of -$81.60 million (-14.00%) on March 31, 2025.
  • Over the past year, NBIX TTM operating profit has increased by +$31.00 million (+6.59%).
  • NBIX TTM operating profit is now -14.77% below its all-time high of $588.30 million, reached on September 30, 2024.

Performance

NBIX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

NBIX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+47.7%-77.5%+6.6%
3 y3 years+180.6%+664.5%+179.5%
5 y5 years+157.3%-59.8%+83.4%

NBIX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+180.6%-87.2%+664.5%-14.8%+201.5%
5 y5-yearat high+180.6%-87.2%+664.5%-14.8%+201.5%
alltimeall timeat high+374.7%-87.2%+118.4%-14.8%+326.0%

NBIX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$23.70M(-83.7%)
$501.40M(-14.0%)
Dec 2024
$583.00M(+47.7%)
$145.00M(-21.5%)
$583.00M(-0.9%)
Sep 2024
-
$184.80M(+24.9%)
$588.30M(+8.0%)
Jun 2024
-
$147.90M(+40.5%)
$544.70M(+15.8%)
Mar 2024
-
$105.30M(-29.9%)
$470.40M(+19.1%)
Dec 2023
$394.80M(+58.6%)
$150.30M(+6.4%)
$394.80M(+13.5%)
Sep 2023
-
$141.20M(+91.8%)
$347.90M(+18.1%)
Jun 2023
-
$73.60M(+147.8%)
$294.50M(+6.9%)
Mar 2023
-
$29.70M(-71.3%)
$275.60M(+10.7%)
Dec 2022
$249.00M(+19.8%)
$103.40M(+17.8%)
$249.00M(+18.8%)
Sep 2022
-
$87.80M(+60.5%)
$209.60M(+26.0%)
Jun 2022
-
$54.70M(+1664.5%)
$166.30M(-7.3%)
Mar 2022
-
$3.10M(-95.2%)
$179.40M(-13.7%)
Dec 2021
$207.80M(-36.5%)
$64.00M(+43.8%)
$207.80M(-3.6%)
Sep 2021
-
$44.50M(-34.4%)
$215.60M(-12.1%)
Jun 2021
-
$67.80M(+115.2%)
$245.30M(-18.3%)
Mar 2021
-
$31.50M(-56.1%)
$300.10M(-8.4%)
Dec 2020
$327.50M(+44.5%)
$71.80M(-3.2%)
$327.50M(-3.9%)
Sep 2020
-
$74.20M(-39.5%)
$340.70M(-4.5%)
Jun 2020
-
$122.60M(+108.1%)
$356.60M(+30.4%)
Mar 2020
-
$58.90M(-30.7%)
$273.40M(+20.7%)
Dec 2019
$226.60M(+444.7%)
$85.00M(-5.7%)
$226.60M(+34.7%)
Sep 2019
-
$90.10M(+128.7%)
$168.18M(+27.0%)
Jun 2019
-
$39.40M(+225.6%)
$132.40M(+45.3%)
Mar 2019
-
$12.10M(-54.5%)
$91.15M(+119.1%)
Dec 2018
$41.60M(-141.0%)
$26.58M(-51.1%)
$41.60M(-26.8%)
Sep 2018
-
$54.32M(-3033.2%)
$56.86M(-1743.3%)
Jun 2018
-
-$1.85M(-95.1%)
-$3.46M(-94.1%)
Mar 2018
-
-$37.45M(-189.5%)
-$58.88M(-41.9%)
Dec 2017
-$101.36M(-31.2%)
$41.83M(-797.8%)
-$101.36M(-46.5%)
Sep 2017
-
-$6.00M(-89.5%)
-$189.45M(-14.6%)
Jun 2017
-
-$57.27M(-28.4%)
-$221.89M(+7.5%)
Mar 2017
-
-$79.93M(+72.8%)
-$206.45M(+40.1%)
Dec 2016
-$147.37M(+56.4%)
-$46.25M(+20.3%)
-$147.37M(+11.8%)
Sep 2016
-
-$38.44M(-8.1%)
-$131.87M(+2.0%)
Jun 2016
-
-$41.83M(+100.5%)
-$129.28M(+14.6%)
Mar 2016
-
-$20.86M(-32.2%)
-$112.77M(+19.7%)
Dec 2015
-$94.20M(+46.3%)
-$30.75M(-14.2%)
-$94.20M(+12.2%)
Sep 2015
-
-$35.84M(+41.6%)
-$83.92M(+29.2%)
Jun 2015
-
-$25.32M(+1006.7%)
-$64.94M(+20.3%)
Mar 2015
-
-$2.29M(-88.8%)
-$53.97M(-16.2%)
Dec 2014
-$64.41M(+29.7%)
-$20.47M(+21.4%)
-$64.41M(+16.1%)
Sep 2014
-
-$16.86M(+17.4%)
-$55.47M(+9.6%)
Jun 2014
-
-$14.36M(+12.9%)
-$50.62M(+2.4%)
Mar 2014
-
-$12.72M(+10.4%)
-$49.43M(-0.5%)
Dec 2013
-$49.68M(-3530.8%)
-$11.53M(-4.0%)
-$49.68M(+68.0%)
Sep 2013
-
-$12.01M(-8.8%)
-$29.57M(+37.4%)
Jun 2013
-
-$13.17M(+1.5%)
-$21.52M(+121.1%)
Mar 2013
-
-$12.97M(-251.2%)
-$9.73M(-772.3%)
Dec 2012
$1.45M(-95.7%)
$8.58M(-316.6%)
$1.45M(-121.7%)
Sep 2012
-
-$3.96M(+187.1%)
-$6.69M(-124.1%)
Jun 2012
-
-$1.38M(-23.0%)
$27.71M(-8.2%)
Mar 2012
-
-$1.79M(-500.9%)
$30.19M(-11.0%)
Dec 2011
$33.92M(-347.2%)
$447.00K(-98.5%)
$33.92M(+1.7%)
Sep 2011
-
$30.44M(+2677.4%)
$33.35M(+520.7%)
Jun 2011
-
$1.10M(-43.5%)
$5.37M(-432.8%)
Mar 2011
-
$1.94M(-1603.1%)
-$1.61M(-88.2%)
Dec 2010
-$13.72M
-$129.00K(-105.2%)
-$13.72M(-47.0%)
DateAnnualQuarterlyTTM
Sep 2010
-
$2.47M(-141.9%)
-$25.87M(-31.9%)
Jun 2010
-
-$5.89M(-42.1%)
-$37.97M(-19.2%)
Mar 2010
-
-$10.17M(-17.2%)
-$46.99M(-8.1%)
Dec 2009
-$51.11M(-40.0%)
-$12.28M(+27.5%)
-$51.11M(-24.3%)
Sep 2009
-
-$9.63M(-35.4%)
-$67.50M(-8.3%)
Jun 2009
-
-$14.90M(+4.2%)
-$73.57M(-6.6%)
Mar 2009
-
-$14.30M(-50.1%)
-$78.78M(-7.6%)
Dec 2008
-$85.25M(-59.8%)
-$28.66M(+82.5%)
-$85.25M(-54.0%)
Sep 2008
-
-$15.70M(-21.9%)
-$185.18M(-6.6%)
Jun 2008
-
-$20.12M(-3.1%)
-$198.30M(-3.6%)
Mar 2008
-
-$20.76M(-83.9%)
-$205.73M(-3.1%)
Dec 2007
-$212.24M(+87.3%)
-$128.59M(+346.1%)
-$212.24M(+112.4%)
Sep 2007
-
-$28.83M(+4.6%)
-$99.91M(-10.2%)
Jun 2007
-
-$27.55M(+1.0%)
-$111.28M(-1.5%)
Mar 2007
-
-$27.27M(+67.7%)
-$113.00M(-0.3%)
Dec 2006
-$113.32M(+352.0%)
-$16.26M(-59.5%)
-$113.32M(-6.8%)
Sep 2006
-
-$40.20M(+37.4%)
-$121.65M(+116.0%)
Jun 2006
-
-$29.26M(+6.1%)
-$56.33M(+69.1%)
Mar 2006
-
-$27.59M(+12.2%)
-$33.32M(+32.9%)
Dec 2005
-$25.07M(-52.1%)
-$24.59M(-197.9%)
-$25.07M(+15.7%)
Sep 2005
-
$25.12M(-501.8%)
-$21.66M(-56.5%)
Jun 2005
-
-$6.25M(-67.7%)
-$49.81M(-12.5%)
Mar 2005
-
-$19.35M(-8.7%)
-$56.95M(+8.8%)
Dec 2004
-$52.33M(-11.0%)
-$21.18M(+598.9%)
-$52.33M(+7.9%)
Sep 2004
-
-$3.03M(-77.4%)
-$48.52M(-17.9%)
Jun 2004
-
-$13.39M(-9.1%)
-$59.06M(+1.5%)
Mar 2004
-
-$14.73M(-15.2%)
-$58.16M(-1.1%)
Dec 2003
-$58.79M(-43.3%)
-$17.37M(+28.0%)
-$58.79M(-28.9%)
Sep 2003
-
-$13.57M(+8.7%)
-$82.69M(-9.7%)
Jun 2003
-
-$12.49M(-18.6%)
-$91.62M(-9.4%)
Mar 2003
-
-$15.35M(-62.8%)
-$101.15M(-2.4%)
Dec 2002
-$103.61M(+136.1%)
-$41.27M(+83.4%)
-$103.61M(+33.3%)
Sep 2002
-
-$22.50M(+2.2%)
-$77.75M(+43.8%)
Jun 2002
-
-$22.02M(+23.6%)
-$54.05M(+13.5%)
Mar 2002
-
-$17.82M(+15.7%)
-$47.62M(+8.5%)
Dec 2001
-$43.88M(+23.3%)
-$15.40M(-1391.2%)
-$43.88M(+10.3%)
Sep 2001
-
$1.19M(-107.7%)
-$39.79M(-21.5%)
Jun 2001
-
-$15.59M(+10.7%)
-$50.67M(+19.3%)
Mar 2001
-
-$14.08M(+24.5%)
-$42.45M(+19.2%)
Dec 2000
-$35.60M(+78.9%)
-$11.31M(+16.8%)
-$35.60M(+21.5%)
Sep 2000
-
-$9.69M(+31.2%)
-$29.29M(+19.0%)
Jun 2000
-
-$7.38M(+2.1%)
-$24.61M(+9.3%)
Mar 2000
-
-$7.23M(+44.5%)
-$22.52M(+13.8%)
Dec 1999
-$19.90M(+60.5%)
-$5.00M(0.0%)
-$19.79M(+7.0%)
Sep 1999
-
-$5.00M(-5.5%)
-$18.49M(+11.5%)
Jun 1999
-
-$5.29M(+17.6%)
-$16.59M(+12.9%)
Mar 1999
-
-$4.50M(+21.6%)
-$14.70M(+16.7%)
Dec 1998
-$12.40M(-2580.0%)
-$3.70M(+19.4%)
-$12.60M(+23.5%)
Sep 1998
-
-$3.10M(-8.8%)
-$10.20M(+36.0%)
Jun 1998
-
-$3.40M(+41.7%)
-$7.50M(+50.0%)
Mar 1998
-
-$2.40M(+84.6%)
-$5.00M(-933.3%)
Dec 1997
$500.00K(-82.8%)
-$1.30M(+225.0%)
$600.00K(-88.5%)
Sep 1997
-
-$400.00K(-55.6%)
$5.20M(+26.8%)
Jun 1997
-
-$900.00K(-128.1%)
$4.10M(-34.9%)
Mar 1997
-
$3.20M(-3.0%)
$6.30M(+117.2%)
Dec 1996
$2.90M
$3.30M(-320.0%)
$2.90M(-825.0%)
Sep 1996
-
-$1.50M(-215.4%)
-$400.00K(-136.4%)
Jun 1996
-
$1.30M(-750.0%)
$1.10M(-650.0%)
Mar 1996
-
-$200.00K
-$200.00K

FAQ

  • What is Neurocrine Biosciences annual operating income?
  • What is the all time high annual operating profit for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual operating profit year-on-year change?
  • What is Neurocrine Biosciences quarterly operating income?
  • What is the all time high quarterly operating profit for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly operating profit year-on-year change?
  • What is Neurocrine Biosciences TTM operating income?
  • What is the all time high TTM operating profit for Neurocrine Biosciences?
  • What is Neurocrine Biosciences TTM operating profit year-on-year change?

What is Neurocrine Biosciences annual operating income?

The current annual operating profit of NBIX is $583.00M

What is the all time high annual operating profit for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual operating income is $583.00M

What is Neurocrine Biosciences annual operating profit year-on-year change?

Over the past year, NBIX annual operating income has changed by +$188.20M (+47.67%)

What is Neurocrine Biosciences quarterly operating income?

The current quarterly operating profit of NBIX is $23.70M

What is the all time high quarterly operating profit for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly operating income is $184.80M

What is Neurocrine Biosciences quarterly operating profit year-on-year change?

Over the past year, NBIX quarterly operating income has changed by -$81.60M (-77.49%)

What is Neurocrine Biosciences TTM operating income?

The current TTM operating profit of NBIX is $501.40M

What is the all time high TTM operating profit for Neurocrine Biosciences?

Neurocrine Biosciences all-time high TTM operating income is $588.30M

What is Neurocrine Biosciences TTM operating profit year-on-year change?

Over the past year, NBIX TTM operating income has changed by +$31.00M (+6.59%)
On this page